Funds Management

Market conditions have shifted dramatically in recent months. But while growth strategies have suffered significant pain, value investors are finally proving their bona fides.

Shareholders in toll road operator Atlas Arteria believe the company will be able to drum up significant offshore interest in the face of a raid on its registry by IFM Investors.

Academically driven global index provider Scientific Beta has taken strides in its commercialisation with its latest offering. It has also prompted the question: is there a point where smart beta becomes dumb alpha?

Everybody wants certainty, but it’s the one thing in short supply in markets today.

The rivers of gold that have flowed over the last decade have not flowed to more innovative products, according to Boston Consulting Group.

Investors are now fretting a recession to go along with a more volatile geopolitical outlook. But on that prospect, it’s the cooler-headed fundies that will prevail.

As Paradice’s emerging market equities strategy hits its three-year anniversary, the outlook for the asset class has never been more uncertain. But the local institutional appetite is voracious.

Value investors have staged their long-prophesied comeback during the highly volatile start to the year. But questions remain about whether this performance will be prolonged.

Investment management still trends “pale, male, and stale”. But a new mentoring program is aiming to close the female participation gap.

The founder of Hyperion Asset Management and ECP has in recent years focused his philanthropic efforts on restoring master works from ages past.

The new corporate collective investment vehicle (CCIV) could create new markets for Australian fund managers and bring international managers to Australian shores.

With a new CEO at the helm, the charitable listed investment companies first set up by Geoff Wilson in 2014 will now start funding organisations focused on addressing mental health issues before they occur.